JPMorgan Chase & Co. Boosts IGM Biosciences (NASDAQ:IGMS) Price Target to $12.00
IGM Biosciences (NASDAQ:IGMS – Free Report) had its price objective upped by JPMorgan Chase & Co. from $11.00 to $12.00 in a report published on Thursday morning, Benzinga reports. They currently have a neutral rating on the stock. Other equities analysts have also recently issued research reports about the company. Wedbush reissued an outperform rating […]
More Stories
Dream Industrial Real Estate Invest Trst (TSE:DIR.UN) Price Target Lowered to C$14.50 at Raymond James
Dream Industrial Real Estate Invest Trst (TSE:DIR.UN – Free Report) had its price target lowered by Raymond James from C$15.75...
Stifel Nicolaus Issues Pessimistic Forecast for Algoma Steel Group (TSE:ASTL) Stock Price
Algoma Steel Group (TSE:ASTL – Free Report) had its target price lowered by Stifel Nicolaus from C$22.00 to C$21.00 in...
StockNews.com Initiates Coverage on Mannatech (NASDAQ:MTEX)
StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX – Free Report) in a report released on Monday morning. The brokerage...
Symbolic Logic (NASDAQ:EVOL) Coverage Initiated at StockNews.com
StockNews.com started coverage on shares of Symbolic Logic (NASDAQ:EVOL – Free Report) in a report released on Monday morning. The...
Cantaloupe (NASDAQ:USAT) Earns Hold Rating from Analysts at StockNews.com
StockNews.com began coverage on shares of Cantaloupe (NASDAQ:USAT – Free Report) in a research note issued to investors on Monday....
Retail Opportunity Investments (NASDAQ:ROIC) Now Covered by StockNews.com
StockNews.com assumed coverage on shares of Retail Opportunity Investments (NASDAQ:ROIC – Free Report) in a research report sent to investors...